The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,242.00
Bid: 12,242.00
Ask: 12,244.00
Change: -4.00 (-0.03%)
Spread: 2.00 (0.016%)
Open: 12,240.00
High: 12,306.00
Low: 12,228.00
Prev. Close: 12,246.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: UK FCA charges NatWest with money-laundering failures

Tue, 16th Mar 2021 08:20

(Alliance News) - The City watchdog has launched criminal proceedings against taxpayer-backed lender NatWest Group for alleged failures under money laundering rules, PA reported Tuesday.

The Financial Conduct Authority alleges that "increasingly large cash deposits" were made into a NatWest customer's account, with around GBP365 million paid in – of which some GBP264 million was in cash.

It claims that NatWest's systems and controls failed to properly monitor and scrutinise this activity, which took place between November 11 2011 and October 19 2016.

NatWest is due to appear at Westminster Magistrates' Court on April 14.

It marks the first time the FCA has launched criminal prosecution under the money laundering regulations and the first time the rules have been used to prosecute a bank.

The FCA said the money laundering rules require firms to "determine, conduct and demonstrate risk sensitive due diligence and ongoing monitoring of its relationships with its customers for the purposes of preventing money laundering".

No individuals are being charged as part of the proceedings.

NatWest shares were down 0.8% early Tuesday.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: up 0.5% at 6,784.44

----------

Hang Seng: up 0.7% at 29,020.58

Nikkei 225: closed up 0.5% at 29,921.09

DJIA: closed up 174.82 points, 0.5%, at 32,953.46

S&P 500: closed up 0.7% at 3,968.94

Nasdaq Composite: closed up 1.1% at 13,459.71

----------

EUR: down at USD1.1922 (USD1.1931)

GBP: down at USD1.3832 (USD1.3885)

USD: up at JPY109.21 (JPY109.08)

Gold: down at USD1,728.85 per ounce (USD1,730.28)

Oil (Brent): down at USD68.23 a barrel (USD68.70)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Tuesday's Key Economic Events still to come

US Federal Open Market Committee meeting starts

1100 CET Germany ZEW Indicator

0830 EDT US import & export price indexes

0830 EDT US retail sales

0855 EDT US Johnson Redbook retail sales index

0915 EDT US industrial production

1000 EDT US NAHB housing market index

1630 EDT US API Weekly statistical bulletin

----------

US and Japanese foreign and defence ministers warned on China, saying they had renewed a commitment to opposing "coercion and destabilising behaviour," during talks in Tokyo. "The US and Japan acknowledged that China's behaviour, where inconsistent with the existing international order, presents political, economic, military and technological challenges," they said in a joint statement on Tuesday. "The ministers committed to opposing coercion and destabilising behaviour towards others in the region," they added.

----------

BROKER RATING CHANGES

----------

JEFFERIES RAISES ASTRAZENECA TO 'BUY' (HOLD) - PRICE TARGET 8850 (8250) PENCE

----------

CREDIT SUISSE RAISES NATWEST TO 'OUTPERFORM' ('NEUTRAL') - TARGET 230 (170) P

----------

CREDIT SUISSE RAISES HSBC TO 'NEUTRAL' (UNDERPERFORM) - PRICE TARGET 440 (400) PENCE

CREDIT SUISSE RAISES BARCLAYS TO 'OUTPERFORM' (NEUTRAL) - PRICE TARGET 210 (155) PENCE

----------

BERENBERG INITIATES B&M EUROPEAN VALUE RETAIL WITH 'BUY' - TARGET 600 PENCE

----------

COMPANIES - FTSE 100

----------

AstraZeneca said it has modified an existing agreement with the US government to supply up to 500,000 additional doses of AZD7442, a long-acting antibody combination which is in late-stage development for the prevention and treatment of Covid-19. The Anglo-Swedish drugmaker said the new US government deal builds on earlier deals for a total of 200,000 doses with the US Department of Health & Human Service and Department of Defense. The value of the extended agreement is USD205 million and is contingent on AZD7442 receiving and Emergency Use Authorisation from the US Food & Drug Administration. AstraZeneca said the total value of current agreements with the US government for the development and supply of AZD7442 in 2021 is about USD726 million. The extended agreement is not anticipated to effect the company's financial guidance for 2021.

----------

AstraZeneca also said it has completed the sale of its 27% stake in Viela Bio Inc to Horizon Therapeutics. It will receive USD775 million in cash proceeds and profit from the Viela stake sale, but this also isn't expected to affect its guidance for 2021.

----------

Chilean copper miner Antofagasta hiked its dividend as it reported positive annual results and a strengthened balance sheet. For 2020, revenue was up 3.3% to USD5.13 billion from USD4.94 billion in 2019. Pretax profit was USD1.41 billion, up 4.4% from USD1.35 billion. Earnings before interest, tax, depreciation and amortisation rose 12% to USD2.74 billion in 2020 from USD2.44 billion the year prior. The miner declared a final dividend of 48.5 cents per share, bringing the total dividend for the year to 54.7 cents per share, up from 17.8 cents in 2019. Chief Executive Ivan Arriagada said: "The year has been challenging, but we have successfully kept our people safe and healthy, achieved our production and exceeded our cost targets, and increased Ebitda by 12.3% to USD2.7 billion, yielding a 53% Ebitda margin...Our resilient operations performed well with high levels of throughput and our Cost & Competitiveness Programme delivered benefits of USD197 million, nearly double the targeted amount. Our balance sheet strengthened even further." Antofagasta said it had USD82 million in net debt at the end of 2020, for a net debt to Ebitda ratio of just 0.03 times.

----------

Plumbing and heating products supplier Ferguson said it delivered good top-line growth in the first half of its financial year and despite "challenging personal and professional" circumstances. For the half year ended January 31, revenue was up 4.2% to USD10.31 billion from USD9.89 billion at the same time the year before, and pretax profit rose 18% to USD739 million from USD628 million. Ferguson declared an interim dividend of 72.9 US cents, having paid out nothing the year before and said that now the disposal of its UK side has completed, a special dividend of 180 cents per share will be paid in May. It also announced a new USD400 million share buy back scheme. Ferguson completed the GBP308 million sale of heating & plumbing distribution business Wolseley UK to US private equity firm Clayton, Dubilier & Rice at the start of February.

----------

COMPANIES - FTSE 250

----------

Stockbroker AJ Bell confirmed it has picked Helena Morrissey as its next chair. Morrissey will join the AJ Bell board as chair designate on July 1 and succeed Les Platts as chair at the next annual general meeting in January next year. Morrissey will step down as a non-executive director of wealth manager St James's Place on July 1 "to avoid any potential conflict of interest", St James's Place said. Morrissey was head of Personal Investing at Legal & General Investment Management and prior to that chief executive of Newton Investment Management.

----------

COMPANIES - GLOBAL

----------

Credit Suisse confirmed that it has made "a strong start" to 2021, achieving the highest level of pretax income in both January and February in a decade. The Swiss bank said its Investment Bank division is benefiting from a "particularly strong" performance in capital markets issuance activity and from a continued "good" performance across sales & trading. Investment Bank year-to-date revenue is up over 50% compared to the prior year, Credit Suisse noted. It also reported increased client activity year-on-year, which was boosting all of its three Wealth Management-related businesses, while net interest income was also stabilising and recurring commissions and fees continued to trend up. "Notwithstanding the continued Covid-19 pandemic, our credit loss experience remains benign, with signs of improvement in the global economy beginning to benefit allowance for credit losses under the current expected credit loss accounting methodology," said Chief Executive Thomas Gottstein. Turning to the suspension and liquidation of the supply chain finance funds - with net asset value of USD10 billion - managed by Credit Suisse Asset Management with assets originated and structured by Greensill Capital, Credit Suisse said its priority remains the recovery of funds for its investors.

----------

Tuesday's Shareholder Meetings

Blackrock Energy & Resources Income Trust PLC - AGM

Blue Prism Group PLC - AGM

Plus500 Ltd - EGM

Starvest PLC - AGM

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.